Giessen, Germany

Andreas Scholz

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Scholz. Retrieved from https://idiyas.com/inventor/andreas-scholz-ugk8a1gm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Scholz

Introduction

Andreas Scholz is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative dosage forms and treatment devices that address specific medical needs.

Latest Patents

One of Scholz's latest patents is for pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. This invention provides a pharmaceutical dosage form for administration twice daily, once daily, or less frequently, which contains the aforementioned compound or a physiologically acceptable salt thereof. Another significant patent involves a device and formulation for the topical treatment of pain affecting the vulvar area of the female human genital organ. This invention includes a device designed for topical treatment, a formulation for use in the device, and a method for administering the treatment.

Career Highlights

Throughout his career, Andreas Scholz has worked with prominent companies such as Grünenthal GmbH. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address various health issues.

Collaborations

Scholz has collaborated with notable colleagues, including Nadja Gruening and Marc Schiller. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Andreas Scholz's contributions to the pharmaceutical field through his patents and innovative solutions demonstrate his commitment to improving healthcare. His work continues to impact the industry positively, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…